MedPath

Evaluation the effects of Bupivacaine plus Magnesium Sulfate with Ropivacaine plus Magnesium Sulfate infiltration on postoperative pai

Phase 2
Conditions
pain.
Generalized pain NOS
R52.9
Registration Number
IRCT20160430027677N18
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

aged 18 to 65 years
American Society of Anesthesiologists physical status classification I and II
lumbar laminectomy with general anesthesia

Exclusion Criteria

Body mass index more than 35 kg/m2
Allergy to the drugs studied
Seizure disease
Severe systemic disease
Coagulation Disorders
mental Disorders
A history of drug addiction

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: In recovery, 6, 12 and 24 hours after surgery. Method of measurement: Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
Mean Arterial Blood Pressure. Timepoint: In recovery, 6, 12 and 24 hours after surgery. Method of measurement: None Invasive Blood Pressure.;Mean pulse Rate. Timepoint: In recovery, 6, 12 and 24 hours after surgery. Method of measurement: Electrocardiogram.
© Copyright 2025. All Rights Reserved by MedPath